DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)
Currently, many human infectious diseases do not developed effective methods of treatment and prevention. One of the latest successes of biotechnology is the use of adenoviral vectors carrying immunodominant antigens of various pathogens as genetically engineered vaccines both preventive and ther...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2017-08-01
|
| Series: | Медицинская иммунология |
| Subjects: | |
| Online Access: | https://www.mimmun.ru/mimmun/article/view/1307 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849401598874222592 |
|---|---|
| author | L. V. Cherenova T. V. Kashtigo Kh. S. Saiadian M. M. Shmarov |
| author_facet | L. V. Cherenova T. V. Kashtigo Kh. S. Saiadian M. M. Shmarov |
| author_sort | L. V. Cherenova |
| collection | DOAJ |
| description | Currently, many human infectious diseases do not developed effective methods of treatment and prevention. One of the latest successes of biotechnology is the use of adenoviral vectors carrying immunodominant antigens of various pathogens as genetically engineered vaccines both preventive and therapeutic. The use of genetic engineering technologies allows not to use in the manufacture of vaccines live viruses and bacteria, reduces the time needed for vaccine creation and production of new vaccines. Adenoviral vectors naturally penetrate into human cells, causing a rather long and significant both humoral and cellular immune response. In the second part of review, we provide information about the ongoing worldwide clinical trials of adenoviral vector-based vaccines against various infectious diseases such as influenza, malaria, Ebola haemorrhagic fever, tuberculosis, hepatitis and several others, like as to consider selection parameters of volunteers, vaccination schedule, doses of drug administration, results of completed experiments, and preliminary data on currently ongoing research. |
| format | Article |
| id | doaj-art-873ea27afa2e4dde939b3d79061df97c |
| institution | Kabale University |
| issn | 1563-0625 2313-741X |
| language | Russian |
| publishDate | 2017-08-01 |
| publisher | St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists |
| record_format | Article |
| series | Медицинская иммунология |
| spelling | doaj-art-873ea27afa2e4dde939b3d79061df97c2025-08-20T03:37:44ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2017-08-0119432935810.15789/1563-0625-2017-4-329-358930DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)L. V. Cherenova0T. V. Kashtigo1Kh. S. Saiadian2M. M. Shmarov3N. Gamaleya Research Institute of Epidemiology and MicrobiologyN. Gamaleya Research Institute of Epidemiology and MicrobiologyFirst Moscow I. Sechenov State Medical UniversityN. Gamaleya Research Institute of Epidemiology and MicrobiologyCurrently, many human infectious diseases do not developed effective methods of treatment and prevention. One of the latest successes of biotechnology is the use of adenoviral vectors carrying immunodominant antigens of various pathogens as genetically engineered vaccines both preventive and therapeutic. The use of genetic engineering technologies allows not to use in the manufacture of vaccines live viruses and bacteria, reduces the time needed for vaccine creation and production of new vaccines. Adenoviral vectors naturally penetrate into human cells, causing a rather long and significant both humoral and cellular immune response. In the second part of review, we provide information about the ongoing worldwide clinical trials of adenoviral vector-based vaccines against various infectious diseases such as influenza, malaria, Ebola haemorrhagic fever, tuberculosis, hepatitis and several others, like as to consider selection parameters of volunteers, vaccination schedule, doses of drug administration, results of completed experiments, and preliminary data on currently ongoing research.https://www.mimmun.ru/mimmun/article/view/1307adenoviral vectorvaccineclinical trialsinfectious diseaseshuman adenoviruschimpanzee adenovirus |
| spellingShingle | L. V. Cherenova T. V. Kashtigo Kh. S. Saiadian M. M. Shmarov DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2) Медицинская иммунология adenoviral vector vaccine clinical trials infectious diseases human adenovirus chimpanzee adenovirus |
| title | DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2) |
| title_full | DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2) |
| title_fullStr | DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2) |
| title_full_unstemmed | DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2) |
| title_short | DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2) |
| title_sort | development of vaccines based on adenoviral vectors a review of foreign clinical studies part 2 |
| topic | adenoviral vector vaccine clinical trials infectious diseases human adenovirus chimpanzee adenovirus |
| url | https://www.mimmun.ru/mimmun/article/view/1307 |
| work_keys_str_mv | AT lvcherenova developmentofvaccinesbasedonadenoviralvectorsareviewofforeignclinicalstudiespart2 AT tvkashtigo developmentofvaccinesbasedonadenoviralvectorsareviewofforeignclinicalstudiespart2 AT khssaiadian developmentofvaccinesbasedonadenoviralvectorsareviewofforeignclinicalstudiespart2 AT mmshmarov developmentofvaccinesbasedonadenoviralvectorsareviewofforeignclinicalstudiespart2 |